NIH-funded research R01 grant

Understanding how a brain protein affects immune responses

Official title: Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain

Funded at Ut Southwestern Medical Center · NIH-10820430 · Data updated 2026-11-12

This study is looking at how a protein called alpha-synuclein, which is connected to Parkinson's disease, affects the brain's ability to fight off infections and inflammation, and it's for anyone interested in understanding more about how we can better treat neurodegenerative diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startSeptember 2, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$300,395
NIH project number5R01NS123431-04
Project IDNIH-10820430 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with neurodegenerative diseases, particularly those with Parkinson's disease or related conditions.

Less likely to help

Patients with acute infections or non-neurological conditions may not receive direct benefits from this research.

What this research studies

This research investigates the role of alpha-synuclein, a protein linked to Parkinson's disease, in the brain's immune responses. It aims to uncover how this protein influences the signaling pathways that help protect neurons from infections and inflammation. By using advanced techniques like induced pluripotent stem cells and CRISPR technology, the researchers will explore the mechanisms by which alpha-synuclein modulates immune signaling in the central nervous system. This could lead to new insights into neurodegenerative diseases and their treatment.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for neurodegenerative diseases by enhancing our understanding of immune responses in the brain.

How similar studies have gone: Previous research has shown promising results in understanding immune responses in the brain, but this specific approach focusing on alpha-synuclein is relatively novel.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Beckham, John David — Ut Southwestern Medical Center
  • Study coordinator: Beckham, John David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.